ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
港股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
荣昌生物
117.700
-0.300
-0.25%
手动刷新
成交量:
149.15万
成交额:
1.75亿
市值:
663.37亿
市盈率:
79.55
高:
119.400
开:
118.800
低:
114.600
收:
118.000
52周最高:
126.600
52周最低:
32.600
股本:
5.64亿
香港流通股本:
2.09亿
量比:
0.81
换手率:
0.72%
股息:
- -
股息率:
- -
每股收益(LYR):
1.480
净资产收益率:
25.37%
总资产收益率:
1.37%
市净率:
16.03
市盈率(LYR):
79.55
市销率:
17.79
数据加载中...
总览
公司
新闻资讯
公告
政策催化叠加价值兑现 国产创新药领域开启景气周期
制药网
·
01/19
生物制品行业深度报告:MNC不断加码IO双抗,2026年重磅催化有望持续
开源证券
·
01/19
JPM大会落幕,开了个寂寞吗?
医药财经
·
01/19
IO+ADC战局悬念再起
药闻社
·
01/17
外企高管转型中国创新药“推销员”,黄仁勋也来共享顶级资本盛宴
第一财经
·
01/17
JPM大会上,5家最可能改变新年竞争格局的中国创新药企
动脉网
·
01/17
荣昌生物:公司尚无药品在欧盟获批上市,无药品向欧盟出口销售
每日经济新闻
·
01/16
荣昌生物(09995)升3.45% 与艾伯维就RC148达成独家授权许可
金吾财讯
·
01/16
异动解读 | 荣昌生物盘中大涨5.09%,因上调股份回购价格上限至116元/股
异动解读
·
01/16
智通港股早知道 | 央行下调各类结构性货币工具25个基点 国家电网“十五五”计划投资4万亿元
智通财经
·
01/16
荣昌生物:调整回购股份价格上限至116元/股
每日经济新闻
·
01/15
研报掘金丨东北证券:维持荣昌生物“买入”评级,看好公司长期发展前景
格隆汇资讯
·
01/15
《大行》交银国际升荣昌生物(09995.HK)目标价至136元 上调今明两年收入预测
阿斯达克财经
·
01/15
华西证券:维持荣昌生物(09995)“增持”评级 RC148双抗56亿美元出海
智通财经
·
01/15
【券商聚焦】华泰证券:超预期创新药BD带动板块共振
金吾财讯
·
01/15
艾伯维与荣昌生物达成重磅合作!56亿美元共同开发实体瘤双特异性抗体
药事纵横
·
01/15
向“领跑者”跨越! 中国双抗药物再迎高光时刻
每日经济新闻
·
01/14
荣昌生物56亿美元订单背后:纾困之后,如何突围创新药深水区?
YD中孚财经
·
01/14
艾伯维再砸下56亿美元!为什么MNC热衷双抗?
动脉新医药
·
01/14
2026开年,创新药迎来暖风
Ofweek维科网
·
01/14
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/09995/news?page=8®ion=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09995","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09995\",,,,,undefined,":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":117.7,"timestamp":1776396619985,"preClose":118,"halted":0,"volume":1491500,"delay":0,"changeRate":-0.002542372881355908,"floatShares":208581239,"shares":563608243,"eps":1.4795205629569326,"marketStatus":"交易中","change":-0.3,"latestTime":"04-17 11:31:40","open":118.8,"high":119.4,"low":114.6,"amount":175303750,"amplitude":0.040678,"askPrice":117.9,"askSize":8500,"bidPrice":117.6,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":1.4795205629569326,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1776398400000},"marketStatusCode":2,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":118,"openAndCloseTimeList":[[1776389400000,1776398400000],[1776402000000,1776412800000]],"volumeRatio":0.809431,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":148.1,"timestamp":1776396599000,"preClose":153.26,"halted":0,"volume":6585100,"delay":0,"premium":"-30.71"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09995\",,,,,undefined,":{"symbol":"09995","floatShares":208581239,"roa":"1.37%","roe":"25.37%","lyrEps":1.479521,"volumeRatio":0.809431,"shares":563608243,"dividePrice":0,"high":119.4,"amplitude":0.040678,"preClose":118,"low":114.6,"week52Low":32.6,"pbRate":"16.03","psRate":"17.79","week52High":126.6,"institutionHeld":0,"latestPrice":117.7,"committee":-0.619048,"eps":1.4795205629569326,"divideRate":0,"volume":1491500,"delay":0,"ttmEps":1.4795205629569326,"open":118.8,"prevYearClose":72,"prevWeekClose":106,"prevMonthClose":95.8,"prevQuarterClose":95.8,"fiveDayClose":106,"twentyDayClose":91.25,"sixtyDayClose":94.25,"earningDate":1777392000000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09995\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"09995","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777426200000,"name":null,"time":"盘后","dateTimestamp":1777392000000,"actualEps":null},{"market":"HK","date":"2026-03-27","symbol":"09995","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1774540800000,"reportTimeType":"pre","actualEps":null},{"market":"HK","date":"2025-10-30","symbol":"09995","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1761753600000,"reportTimeType":"","actualEps":null},{"date":"2025-08-22","symbol":"09995","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755826200000,"name":null,"time":"","dateTimestamp":1755792000000,"actualEps":null},{"market":"HK","date":"2025-04-28","symbol":"09995","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1745769600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09995\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09995\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":16,"updateTime":1776096000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09995\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09995","date":"2026-04-15","current":79.760476,"percent":0.860276,"low":-74.629684,"twenty":-44.728018,"median":-21.714085,"eighty":64.250264,"high":173.067485,"avg":1.29737,"sd":63.042718,"marketCap":85061641097},"quantilePoints":[{"date":"2021-04-23","current":-61.700015,"twenty":-111.178495,"median":-101.019451,"eighty":-62.218231,"marketCap":51432853710},{"date":"2021-04-30","current":-60.159265,"twenty":-110.810066,"median":-98.425385,"eighty":-62.218231,"marketCap":50355212965},{"date":"2021-05-07","current":-55.876334,"twenty":-110.50456,"median":-98.089656,"eighty":-61.453251,"marketCap":47073307062},{"date":"2021-05-14","current":-54.021824,"twenty":-109.740958,"median":-96.828664,"eighty":-59.770283,"marketCap":45481337780},{"date":"2021-05-21","current":-59.154611,"twenty":-109.051592,"median":-94.493563,"eighty":-58.939917,"marketCap":49816392593},{"date":"2021-05-28","current":-61.399737,"twenty":-108.679513,"median":-92.903768,"eighty":-58.939917,"marketCap":52216592433},{"date":"2021-06-04","current":-63.717745,"twenty":-108.516905,"median":-91.108086,"eighty":-59.126143,"marketCap":53931020890},{"date":"2021-06-11","current":-72.172415,"twenty":-108.35756,"median":-90.61806,"eighty":-59.167491,"marketCap":61082636739},{"date":"2021-06-18","current":-74.629684,"twenty":-108.301513,"median":-86.534807,"eighty":-59.381301,"marketCap":62650114185},{"date":"2021-06-25","current":-72.341215,"twenty":-108.214816,"median":-78.242373,"eighty":-60.213289,"marketCap":60690767377},{"date":"2021-07-02","current":-67.964193,"twenty":-108.052107,"median":-74.252944,"eighty":-60.429384,"marketCap":56919024772},{"date":"2021-07-09","current":-59.718594,"twenty":-107.882309,"median":-73.744805,"eighty":-60.429384,"marketCap":49963343604},{"date":"2021-07-16","current":-62.705815,"twenty":-107.867337,"median":-72.569506,"eighty":-60.919919,"marketCap":52461510784},{"date":"2021-07-23","current":-55.948805,"twenty":-107.767547,"median":-72.053008,"eighty":-60.159265,"marketCap":46803896876},{"date":"2021-07-30","current":-57.920716,"twenty":-107.734281,"median":-71.078402,"eighty":-59.127186,"marketCap":48616292673},{"date":"2021-08-06","current":-56.27668,"twenty":-107.643074,"median":-68.401884,"eighty":-58.400275,"marketCap":47122290732},{"date":"2021-08-13","current":-63.093677,"twenty":-107.158096,"median":-68.183038,"eighty":-58.400275,"marketCap":52902363816},{"date":"2021-08-20","current":-55.656789,"twenty":-107.119802,"median":-66.449956,"eighty":-58.400275,"marketCap":46534486690},{"date":"2021-08-27","current":-45.356144,"twenty":-106.757513,"median":-65.301335,"eighty":-58.130844,"marketCap":48689768178},{"date":"2021-09-03","current":-46.934121,"twenty":-106.757165,"median":-64.67229,"eighty":-57.71074,"marketCap":50404196635},{"date":"2021-09-10","current":-47.860092,"twenty":-106.367613,"median":-64.266493,"eighty":-57.193566,"marketCap":51530821050},{"date":"2021-09-17","current":-46.861329,"twenty":-105.225625,"median":-63.825957,"eighty":-56.27668,"marketCap":50306229295},{"date":"2021-09-24","current":-46.429184,"twenty":-104.365303,"median":-63.717745,"eighty":-55.832425,"marketCap":49865376263},{"date":"2021-09-30","current":-44.819729,"twenty":-102.2899,"median":-63.093677,"eighty":-55.572701,"marketCap":48297898817},{"date":"2021-10-08","current":-44.162631,"twenty":-101.031545,"median":-62.668689,"eighty":-53.522283,"marketCap":47587635599},{"date":"2021-10-15","current":-46.33557,"twenty":-100.798107,"median":-62.617621,"eighty":-52.279468,"marketCap":49963343604},{"date":"2021-10-22","current":-46.14058,"twenty":-99.674882,"median":-62.399641,"eighty":-49.176023,"marketCap":50110294614},{"date":"2021-10-29","current":-43.813344,"twenty":-98.437921,"median":-62.320574,"eighty":-47.92875,"marketCap":47465176423},{"date":"2021-11-05","current":-41.800221,"twenty":-98.265189,"median":-62.057824,"eighty":-46.944318,"marketCap":45358878605},{"date":"2021-11-12","current":-44.95528,"twenty":-98.107213,"median":-61.640907,"eighty":-46.762192,"marketCap":48983670200},{"date":"2021-11-19","current":-48.935634,"twenty":-97.963919,"median":-61.410989,"eighty":-46.762192,"marketCap":53245249507},{"date":"2021-11-26","current":-47.299814,"twenty":-97.60301,"median":-61.270076,"eighty":-46.771745,"marketCap":51481837380},{"date":"2021-12-03","current":-44.899065,"twenty":-96.931841,"median":-61.013572,"eighty":-46.7473,"marketCap":48959178364},{"date":"2021-12-10","current":-42.804509,"twenty":-95.944462,"median":-60.294325,"eighty":-46.523722,"marketCap":46754913205},{"date":"2021-12-17","current":-36.057846,"twenty":-94.673249,"median":-59.718594,"eighty":-46.256818,"marketCap":39358379005},{"date":"2021-12-24","current":-31.495293,"twenty":-93.358231,"median":-59.140899,"eighty":-46.041731,"marketCap":34411028315},{"date":"2021-12-31","current":-34.849225,"twenty":-92.983055,"median":-59.031256,"eighty":-45.859653,"marketCap":38158279085},{"date":"2022-01-07","current":-28.201185,"twenty":-32.342132,"median":-30.132105,"eighty":-28.20953,"marketCap":30761744885},{"date":"2022-01-14","current":-31.186894,"twenty":-32.89668,"median":-31.127838,"eighty":-28.647535,"marketCap":34092634459},{"date":"2022-01-21","current":-27.561501,"twenty":-32.342132,"median":-30.132105,"eighty":-28.40484,"marketCap":30198432678},{"date":"2022-01-28","current":-21.558809,"twenty":-32.035486,"median":-29.108535,"eighty":-26.538489,"marketCap":23561145366},{"date":"2022-02-04","current":-22.645609,"twenty":-31.912824,"median":-28.767377,"eighty":-23.805398,"marketCap":24736753451},{"date":"2022-02-11","current":-22.085308,"twenty":-31.186894,"median":-28.215094,"eighty":-22.891215,"marketCap":24173441243},{"date":"2022-02-18","current":-23.847784,"twenty":-31.068783,"median":-27.57843,"eighty":-22.891215,"marketCap":26230755392},{"date":"2022-02-25","current":-27.987219,"twenty":-30.989991,"median":-25.460984,"eighty":-22.983644,"marketCap":30859712226},{"date":"2022-03-04","current":-26.644287,"twenty":-30.132105,"median":-27.57843,"eighty":-23.199301,"marketCap":29390202120},{"date":"2022-03-11","current":-23.904934,"twenty":-30.129883,"median":-25.460984,"eighty":-23.199301,"marketCap":26328722732},{"date":"2022-03-18","current":-24.75972,"twenty":-30.113176,"median":-25.050449,"eighty":-22.891215,"marketCap":27161445125},{"date":"2022-03-25","current":-26.120522,"twenty":-29.816798,"median":-25.096927,"eighty":-22.891215,"marketCap":28655447107},{"date":"2022-04-01","current":77.302764,"twenty":-29.281242,"median":-24.866411,"eighty":-22.555007,"marketCap":26294960249},{"date":"2022-04-08","current":78.862537,"twenty":-29.004912,"median":-24.593574,"eighty":-22.220495,"marketCap":26837150366},{"date":"2022-04-14","current":68.401325,"twenty":-28.733687,"median":-24.291571,"eighty":-21.672823,"marketCap":23238667972},{"date":"2022-04-22","current":59.38177,"twenty":-28.57189,"median":-23.956867,"eighty":28.369753,"marketCap":19797279085},{"date":"2022-04-29","current":93.975537,"twenty":-28.448772,"median":-23.847784,"eighty":62.397192,"marketCap":19405759720},{"date":"2022-05-06","current":84.438111,"twenty":-28.302958,"median":-23.685967,"eighty":68.061851,"marketCap":17291463648},{"date":"2022-05-13","current":84.26205,"twenty":-28.215094,"median":-23.447312,"eighty":77.302764,"marketCap":16946668364},{"date":"2022-05-20","current":91.005193,"twenty":-28.201185,"median":-23.021317,"eighty":79.560132,"marketCap":18559643435},{"date":"2022-05-27","current":85.65593,"twenty":-28.063221,"median":-22.694279,"eighty":84.438111,"marketCap":17453558117},{"date":"2022-06-02","current":97.413657,"twenty":-28.002419,"median":-22.555007,"eighty":85.027384,"marketCap":19955887542},{"date":"2022-06-10","current":121.08876,"twenty":-27.964701,"median":-22.320166,"eighty":85.657029,"marketCap":24639135574},{"date":"2022-06-17","current":112.243767,"twenty":-27.668102,"median":-21.837848,"eighty":86.461323,"marketCap":22814315658},{"date":"2022-06-24","current":138.513431,"twenty":-27.568273,"median":-21.152123,"eighty":88.329765,"marketCap":28265895756},{"date":"2022-06-30","current":135.17268,"twenty":-27.317647,"median":18.045964,"eighty":90.989165,"marketCap":27536670920},{"date":"2022-07-08","current":155.401591,"twenty":-26.848603,"median":59.38177,"eighty":94.601616,"marketCap":31690187561},{"date":"2022-07-15","current":147.430983,"twenty":-26.330028,"median":63.759757,"eighty":108.127926,"marketCap":29786156847},{"date":"2022-07-22","current":149.683867,"twenty":-25.950446,"median":68.401325,"eighty":112.365591,"marketCap":30261156635},{"date":"2022-07-29","current":139.292552,"twenty":-25.611415,"median":74.118463,"eighty":121.073758,"marketCap":28194724308},{"date":"2022-08-05","current":170.832661,"twenty":-25.24255,"median":78.264822,"eighty":130.267953,"marketCap":34490801175},{"date":"2022-08-12","current":165.66095,"twenty":-25.041153,"median":80.098899,"eighty":137.691277,"marketCap":33492222411},{"date":"2022-08-19","current":156.977725,"twenty":-24.985449,"median":84.26205,"eighty":139.854023,"marketCap":31419036410},{"date":"2022-08-26","current":153.265781,"twenty":-24.845072,"median":84.736706,"eighty":143.281382,"marketCap":30432980157},{"date":"2022-09-02","current":114.627134,"twenty":-24.70066,"median":85.159142,"eighty":143.281382,"marketCap":30146745213},{"date":"2022-09-09","current":112.985497,"twenty":-24.580031,"median":85.568264,"eighty":141.683237,"marketCap":29601873783},{"date":"2022-09-16","current":110.269457,"twenty":-24.452997,"median":85.786628,"eighty":141.419537,"marketCap":28623324208},{"date":"2022-09-23","current":96.13607,"twenty":-24.301997,"median":86.436494,"eighty":140.91499,"marketCap":24475585232},{"date":"2022-09-30","current":108.363934,"twenty":-24.147183,"median":87.130216,"eighty":140.101636,"marketCap":27641419775},{"date":"2022-10-07","current":108.618741,"twenty":-23.988026,"median":88.390695,"eighty":139.345548,"marketCap":27704822753},{"date":"2022-10-14","current":117.312506,"twenty":-23.896423,"median":90.978479,"eighty":139.169137,"marketCap":29604919619},{"date":"2022-10-21","current":148.599861,"twenty":-23.85946,"median":91.975637,"eighty":139.169137,"marketCap":37243770475},{"date":"2022-10-28","current":122.824724,"twenty":-23.839307,"median":95.490683,"eighty":140.349249,"marketCap":36729389886},{"date":"2022-11-04","current":139.368351,"twenty":-23.781512,"median":96.774864,"eighty":140.35116,"marketCap":42082126675},{"date":"2022-11-11","current":131.471349,"twenty":-23.659909,"median":100.242866,"eighty":140.35116,"marketCap":40051405108},{"date":"2022-11-18","current":134.599065,"twenty":-23.534005,"median":101.24992,"eighty":139.36644,"marketCap":40863760164},{"date":"2022-11-25","current":126.242208,"twenty":-23.39771,"median":103.45693,"eighty":139.356765,"marketCap":38022583891},{"date":"2022-12-02","current":120.903459,"twenty":-23.171239,"median":106.217146,"eighty":139.33742,"marketCap":37043091466},{"date":"2022-12-09","current":126.933334,"twenty":-23.043921,"median":107.461854,"eighty":139.169137,"marketCap":39251796716},{"date":"2022-12-16","current":125.384258,"twenty":-22.965158,"median":108.509714,"eighty":138.643067,"marketCap":38682333125},{"date":"2022-12-23","current":133.963734,"twenty":-22.851828,"median":109.340043,"eighty":138.23938,"marketCap":41342060453},{"date":"2022-12-30","current":133.676061,"twenty":-22.733666,"median":109.574656,"eighty":137.417225,"marketCap":41754477029},{"date":"2023-01-06","current":137.016733,"twenty":-22.665077,"median":110.05109,"eighty":138.578249,"marketCap":43237639030},{"date":"2023-01-13","current":153.096922,"twenty":-22.591248,"median":110.688928,"eighty":139.314986,"marketCap":49235937592},{"date":"2023-01-20","current":145.771346,"twenty":-22.545246,"median":111.003569,"eighty":140.286435,"marketCap":46477754662},{"date":"2023-01-27","current":147.4125,"twenty":-22.538739,"median":111.593131,"eighty":140.924568,"marketCap":47010635890},{"date":"2023-02-03","current":160.007008,"twenty":-22.38604,"median":112.458483,"eighty":141.614511,"marketCap":51291329494},{"date":"2023-02-10","current":140.49558,"twenty":-22.254292,"median":112.889934,"eighty":143.120199,"marketCap":44766189324},{"date":"2023-02-17","current":134.478472,"twenty":-22.085308,"median":114.627134,"eighty":143.341837,"marketCap":42443662580},{"date":"2023-02-24","current":127.409261,"twenty":-21.837848,"median":118.167434,"eighty":143.120199,"marketCap":39720874353},{"date":"2023-03-03","current":-36.898264,"twenty":-22.538739,"median":114.627134,"eighty":142.417304,"marketCap":40178555697},{"date":"2023-03-10","current":-35.138959,"twenty":-35.827688,"median":-35.395391,"eighty":-35.088739,"marketCap":37980427930},{"date":"2023-03-17","current":-36.720269,"twenty":-64.544867,"median":-35.076183,"eighty":126.969822,"marketCap":40073622662},{"date":"2023-03-24","current":-31.863689,"twenty":-64.433262,"median":-35.138959,"eighty":126.734892,"marketCap":35172773764},{"date":"2023-03-31","current":-28.861713,"twenty":-64.342235,"median":-34.766608,"eighty":126.386364,"marketCap":31615683306},{"date":"2023-04-06","current":-30.117919,"twenty":-64.282636,"median":-34.399028,"eighty":126.219888,"marketCap":32970475231},{"date":"2023-04-14","current":-34.731674,"twenty":-64.23959,"median":-34.399028,"eighty":126.130609,"marketCap":38058755490},{"date":"2023-04-21","current":-32.91479,"twenty":-64.211469,"median":-33.962061,"eighty":125.384258,"marketCap":36049272444},{"date":"2023-04-28","current":-30.913582,"twenty":-63.825957,"median":-33.853262,"eighty":125.076062,"marketCap":33605389443},{"date":"2023-05-05","current":-30.047356,"twenty":-63.744203,"median":-33.242914,"eighty":124.981573,"marketCap":32717298376},{"date":"2023-05-12","current":-28.854997,"twenty":-63.718949,"median":-32.898538,"eighty":124.301673,"marketCap":31202634865},{"date":"2023-05-19","current":-28.633193,"twenty":-63.588332,"median":-32.526113,"eighty":124.068107,"marketCap":32975977850},{"date":"2023-05-25","current":-27.129433,"twenty":-63.291166,"median":-32.219478,"eighty":123.994899,"marketCap":31115574293},{"date":"2023-06-02","current":-25.706819,"twenty":-63.102056,"median":-31.888257,"eighty":123.726492,"marketCap":29383956040},{"date":"2023-06-09","current":-28.261026,"twenty":-62.922865,"median":-31.620007,"eighty":123.310624,"marketCap":32256914330},{"date":"2023-06-16","current":-28.322083,"twenty":-62.747085,"median":-31.404418,"eighty":123.134174,"marketCap":32171788799},{"date":"2023-06-23","current":-24.968936,"twenty":-62.676114,"median":-31.185251,"eighty":123.009613,"marketCap":28208163899},{"date":"2023-06-30","current":-24.730255,"twenty":-62.62795,"median":-31.068783,"eighty":122.749013,"marketCap":27685792734},{"date":"2023-07-07","current":-28.212835,"twenty":-62.618604,"median":-30.855831,"eighty":122.142638,"marketCap":31522964184},{"date":"2023-07-14","current":-29.951636,"twenty":-62.580693,"median":-30.660024,"eighty":121.363916,"marketCap":33935379467},{"date":"2023-07-21","current":-28.856482,"twenty":-62.479455,"median":-30.264762,"eighty":121.238908,"marketCap":32542613247},{"date":"2023-07-28","current":-31.797053,"twenty":-62.381263,"median":-30.466389,"eighty":121.119679,"marketCap":35820431334},{"date":"2023-08-04","current":-27.229807,"twenty":-62.351837,"median":-30.264762,"eighty":121.078758,"marketCap":30726267924},{"date":"2023-08-11","current":-26.158064,"twenty":-62.339496,"median":-30.117919,"eighty":120.999637,"marketCap":29350246084},{"date":"2023-08-18","current":-26.392498,"twenty":-62.321493,"median":-30.08547,"eighty":120.788166,"marketCap":29401264776},{"date":"2023-08-25","current":-22.689941,"twenty":-62.22541,"median":-30.047356,"eighty":120.451588,"marketCap":29617776953},{"date":"2023-09-01","current":-22.948659,"twenty":-62.076864,"median":-29.634873,"eighty":119.951691,"marketCap":30079863456},{"date":"2023-09-08","current":-21.158444,"twenty":-61.9147,"median":-29.246688,"eighty":119.421351,"marketCap":27406853101},{"date":"2023-09-15","current":-23.230766,"twenty":-61.686168,"median":-29.119191,"eighty":119.12794,"marketCap":30324479084},{"date":"2023-09-22","current":-23.844099,"twenty":-61.645805,"median":-29.05253,"eighty":118.33842,"marketCap":30989011034},{"date":"2023-09-29","current":-23.681557,"twenty":-61.56242,"median":-28.882661,"eighty":116.693843,"marketCap":30830546170},{"date":"2023-10-06","current":-23.373451,"twenty":-61.467338,"median":-28.855739,"eighty":115.538105,"marketCap":30414858330},{"date":"2023-10-13","current":-25.270885,"twenty":-61.408739,"median":-28.812749,"eighty":114.310158,"marketCap":32834786504},{"date":"2023-10-20","current":-22.05562,"twenty":-61.376158,"median":-28.720932,"eighty":113.030904,"marketCap":28612996773},{"date":"2023-10-27","current":-23.699202,"twenty":-61.281844,"median":-28.695538,"eighty":112.985497,"marketCap":30732043662},{"date":"2023-11-03","current":-22.560568,"twenty":-61.258308,"median":-28.598925,"eighty":112.794372,"marketCap":32431540247},{"date":"2023-11-10","current":-23.039107,"twenty":-61.257015,"median":-28.495408,"eighty":112.548327,"marketCap":33112534384},{"date":"2023-11-17","current":-22.579804,"twenty":-61.013572,"median":-28.322083,"eighty":112.458483,"marketCap":32745094940},{"date":"2023-11-24","current":-22.908278,"twenty":-60.919919,"median":-28.213964,"eighty":112.243767,"marketCap":33494945323},{"date":"2023-12-01","current":-23.943252,"twenty":-60.429384,"median":-28.158852,"eighty":112.115883,"marketCap":35153379509},{"date":"2023-12-08","current":-23.264791,"twenty":-60.159265,"median":-28.080936,"eighty":111.070378,"marketCap":34019208398},{"date":"2023-12-15","current":-22.50608,"twenty":-59.92203,"median":-28.032761,"eighty":110.936759,"marketCap":33099814945},{"date":"2023-12-22","current":-19.463125,"twenty":-59.718594,"median":-27.952179,"eighty":110.733956,"marketCap":28605406439},{"date":"2023-12-29","current":-21.071721,"twenty":-59.399524,"median":-27.893463,"eighty":110.706939,"marketCap":31134722075},{"date":"2024-01-05","current":-19.423825,"twenty":-59.17393,"median":-27.641831,"eighty":110.52114,"marketCap":28497448951},{"date":"2024-01-12","current":-19.433722,"twenty":-59.143641,"median":-27.595529,"eighty":110.262777,"marketCap":28527147302},{"date":"2024-01-19","current":-15.049387,"twenty":-59.119177,"median":-27.450786,"eighty":110.091423,"marketCap":22060951550},{"date":"2024-01-26","current":-13.697601,"twenty":-59.046437,"median":-27.275984,"eighty":109.809994,"marketCap":20001216814},{"date":"2024-02-02","current":-11.782972,"twenty":-58.904576,"median":-27.129433,"eighty":109.609895,"marketCap":17183543174},{"date":"2024-02-09","current":-14.598698,"twenty":-58.657161,"median":-26.813103,"eighty":109.375092,"marketCap":21394666798},{"date":"2024-02-16","current":-14.904268,"twenty":-58.400275,"median":-26.660474,"eighty":109.340043,"marketCap":21847207161},{"date":"2024-02-23","current":-13.216885,"twenty":-58.367837,"median":-26.529244,"eighty":108.97788,"marketCap":22129618148},{"date":"2024-03-01","current":-13.976685,"twenty":-58.241017,"median":-26.392498,"eighty":108.618741,"marketCap":23416380098},{"date":"2024-03-08","current":-13.79208,"twenty":-58.189698,"median":-26.132957,"eighty":108.400686,"marketCap":23117370493},{"date":"2024-03-15","current":-16.589002,"twenty":-58.130844,"median":-25.9526,"eighty":108.363934,"marketCap":27780774466},{"date":"2024-03-22","current":-15.384991,"twenty":-58.097714,"median":-25.614187,"eighty":107.461854,"marketCap":25740908961},{"date":"2024-03-28","current":-15.207986,"twenty":-57.956116,"median":-25.39989,"eighty":106.880701,"marketCap":25363377330},{"date":"2024-04-05","current":-15.734403,"twenty":-57.838332,"median":-25.270885,"eighty":106.609484,"marketCap":25732525767},{"date":"2024-04-12","current":-16.52439,"twenty":-57.71315,"median":-25.117251,"eighty":106.257835,"marketCap":27039839481},{"date":"2024-04-19","current":-14.627077,"twenty":-57.692947,"median":-24.973101,"eighty":105.76348,"marketCap":23914718894},{"date":"2024-04-26","current":-16.67171,"twenty":-57.600571,"median":-24.925601,"eighty":104.615663,"marketCap":27224008700},{"date":"2024-05-03","current":-16.112051,"twenty":-57.441419,"median":-24.895523,"eighty":103.378899,"marketCap":26729431803},{"date":"2024-05-10","current":-16.377973,"twenty":-57.197857,"median":-24.75972,"eighty":102.804224,"marketCap":27235094567},{"date":"2024-05-17","current":-15.399952,"twenty":-57.193566,"median":-24.661287,"eighty":101.754015,"marketCap":25571145311},{"date":"2024-05-24","current":-13.603765,"twenty":-57.089427,"median":-24.506525,"eighty":100.745825,"marketCap":22537043211},{"date":"2024-05-31","current":-13.238353,"twenty":-56.398963,"median":-24.343703,"eighty":100.629922,"marketCap":21953996051},{"date":"2024-06-07","current":-13.388977,"twenty":-56.333181,"median":-24.241847,"eighty":100.242866,"marketCap":22176248147},{"date":"2024-06-14","current":-13.949993,"twenty":-56.28798,"median":-24.181624,"eighty":98.469816,"marketCap":23084292080},{"date":"2024-06-21","current":-13.782635,"twenty":-56.102966,"median":-24.120776,"eighty":97.536236,"marketCap":22759604002},{"date":"2024-06-28","current":-12.694723,"twenty":-55.970951,"median":-24.050916,"eighty":96.391587,"marketCap":20954411871},{"date":"2024-07-05","current":-11.591639,"twenty":-55.905322,"median":-23.997412,"eighty":95.778868,"marketCap":19129462611},{"date":"2024-07-12","current":-8.426474,"twenty":-55.744607,"median":-23.96574,"eighty":95.510703,"marketCap":13926477952},{"date":"2024-07-19","current":-8.165768,"twenty":-55.62877,"median":-23.890334,"eighty":94.581595,"marketCap":13495859582},{"date":"2024-07-26","current":-7.330302,"twenty":-55.607505,"median":-23.862379,"eighty":92.833947,"marketCap":12160064702},{"date":"2024-08-02","current":-7.760251,"twenty":-55.556161,"median":-23.824748,"eighty":91.956186,"marketCap":12865794596},{"date":"2024-08-09","current":-7.717663,"twenty":-55.451852,"median":-23.729756,"eighty":91.35447,"marketCap":12880465372},{"date":"2024-08-16","current":-7.820776,"twenty":-54.910331,"median":-23.683762,"eighty":90.989165,"marketCap":13057628296},{"date":"2024-08-23","current":-6.681511,"twenty":-54.245484,"median":-23.623827,"eighty":89.55601,"marketCap":11581466453},{"date":"2024-08-30","current":-7.039095,"twenty":-53.272512,"median":-23.5563,"eighty":88.538426,"marketCap":12283200316},{"date":"2024-09-06","current":-6.7922,"twenty":-52.723148,"median":-23.447312,"eighty":88.370385,"marketCap":11858076004},{"date":"2024-09-13","current":-7.066928,"twenty":-52.660497,"median":-23.404577,"eighty":87.744641,"marketCap":12305412122},{"date":"2024-09-20","current":-6.256413,"twenty":-52.399937,"median":-23.362665,"eighty":87.1805,"marketCap":10959418750},{"date":"2024-09-27","current":-8.398189,"twenty":-51.790657,"median":-23.277649,"eighty":86.751531,"marketCap":14799661709},{"date":"2024-10-04","current":-9.885967,"twenty":-51.308014,"median":-23.256528,"eighty":86.535808,"marketCap":17342357562},{"date":"2024-10-10","current":-9.123971,"twenty":-50.86469,"median":-23.227086,"eighty":86.436494,"marketCap":15901996537},{"date":"2024-10-18","current":-8.631147,"twenty":-49.97335,"median":-23.15308,"eighty":85.916958,"marketCap":14964624891},{"date":"2024-10-25","current":-8.319585,"twenty":-49.389686,"median":-23.0927,"eighty":85.911829,"marketCap":14423526903},{"date":"2024-11-01","current":-10.539504,"twenty":-49.334584,"median":-23.049049,"eighty":85.661427,"marketCap":17867084666},{"date":"2024-11-08","current":-10.03231,"twenty":-49.203604,"median":-23.003561,"eighty":85.65593,"marketCap":16930116284},{"date":"2024-11-15","current":-9.482828,"twenty":-49.0265,"median":-22.971263,"eighty":85.480597,"marketCap":15833372775},{"date":"2024-11-22","current":-9.636818,"twenty":-48.935634,"median":-22.924014,"eighty":85.35845,"marketCap":16082867254},{"date":"2024-11-29","current":-10.150186,"twenty":-48.644471,"median":-22.893864,"eighty":85.159142,"marketCap":16928265521},{"date":"2024-12-06","current":-10.32638,"twenty":-48.426145,"median":-22.867809,"eighty":84.994445,"marketCap":17181552175},{"date":"2024-12-13","current":-9.67298,"twenty":-48.299871,"median":-22.727657,"eighty":84.990497,"marketCap":16079725012},{"date":"2024-12-20","current":-8.930565,"twenty":-48.115701,"median":-22.689941,"eighty":84.482915,"marketCap":14764085743},{"date":"2024-12-27","current":-8.62611,"twenty":-48.103564,"median":-22.687211,"eighty":84.456033,"marketCap":14249695006},{"date":"2025-01-03","current":-7.844244,"twenty":-48.069978,"median":-22.635169,"eighty":84.367687,"marketCap":12970798180},{"date":"2025-01-10","current":-6.899,"twenty":-47.963078,"median":-22.606356,"eighty":82.864264,"marketCap":11364570453},{"date":"2025-01-17","current":-7.281709,"twenty":-47.855538,"median":-22.569364,"eighty":80.715617,"marketCap":12004679780},{"date":"2025-01-24","current":-7.90239,"twenty":-47.817831,"median":-22.538739,"eighty":80.206653,"marketCap":13109571590},{"date":"2025-01-28","current":-7.830082,"twenty":-47.786954,"median":-22.536332,"eighty":79.775639,"marketCap":13051637286},{"date":"2025-02-07","current":-8.10776,"twenty":-47.733736,"median":-22.510897,"eighty":79.002056,"marketCap":13444256315},{"date":"2025-02-14","current":-8.675379,"twenty":-47.723515,"median":-22.409794,"eighty":78.384365,"marketCap":14351124280},{"date":"2025-02-21","current":-8.829208,"twenty":-47.662153,"median":-22.305993,"eighty":77.601719,"marketCap":14685696572},{"date":"2025-02-28","current":-9.413425,"twenty":-47.505575,"median":-22.230757,"eighty":77.3294,"marketCap":15605829252},{"date":"2025-03-07","current":-9.967089,"twenty":-47.434121,"median":-22.070464,"eighty":72.207882,"marketCap":15689959340},{"date":"2025-03-14","current":-9.149769,"twenty":-47.324869,"median":-21.837848,"eighty":70.457384,"marketCap":14408592247},{"date":"2025-03-21","current":-10.775148,"twenty":-47.027654,"median":-21.701714,"eighty":68.788698,"marketCap":16961494875},{"date":"2025-03-28","current":-12.508915,"twenty":-46.93922,"median":-21.388971,"eighty":67.043428,"marketCap":19650825784},{"date":"2025-04-03","current":-13.644787,"twenty":-46.890446,"median":-21.071901,"eighty":65.127989,"marketCap":21442671493},{"date":"2025-04-11","current":-14.55207,"twenty":-46.8143,"median":-20.69563,"eighty":63.696239,"marketCap":22671486815},{"date":"2025-04-17","current":-14.86596,"twenty":-46.77548,"median":-20.578451,"eighty":62.397192,"marketCap":23191203045},{"date":"2025-04-25","current":-17.630442,"twenty":-46.763582,"median":-20.249024,"eighty":60.540137,"marketCap":27557128285},{"date":"2025-05-02","current":-18.216063,"twenty":-46.760802,"median":-20.027819,"eighty":59.38177,"marketCap":26691297456},{"date":"2025-05-09","current":-16.603624,"twenty":-46.742799,"median":-19.959547,"eighty":55.453902,"marketCap":24499442992},{"date":"2025-05-16","current":-17.9661,"twenty":-46.708807,"median":-19.533832,"eighty":54.286547,"marketCap":26726423299},{"date":"2025-05-23","current":-21.245146,"twenty":-46.609709,"median":-19.889069,"eighty":5.927982,"marketCap":31698876925},{"date":"2025-05-30","current":-21.679337,"twenty":-46.562927,"median":-19.998195,"eighty":-6.235145,"marketCap":32488925137},{"date":"2025-06-06","current":-21.880814,"twenty":-46.512642,"median":-20.053415,"eighty":-6.503389,"marketCap":32874517600},{"date":"2025-06-13","current":-23.907285,"twenty":-46.460055,"median":-20.123061,"eighty":-6.618431,"marketCap":35933363693},{"date":"2025-06-20","current":-23.218674,"twenty":-46.433283,"median":-20.459133,"eighty":-6.643753,"marketCap":34829957765},{"date":"2025-06-27","current":-23.331192,"twenty":-46.354293,"median":-20.645823,"eighty":-6.64763,"marketCap":35096752511},{"date":"2025-07-04","current":-27.486633,"twenty":-46.256818,"median":-20.745436,"eighty":-6.66252,"marketCap":41349663044},{"date":"2025-07-11","current":-25.259702,"twenty":-46.166074,"median":-20.952825,"eighty":-6.677827,"marketCap":37961289497},{"date":"2025-07-18","current":-28.535334,"twenty":-46.09369,"median":-21.158444,"eighty":-6.683832,"marketCap":42850433832},{"date":"2025-07-25","current":-26.122139,"twenty":-46.058434,"median":-21.47389,"eighty":-6.692503,"marketCap":39369282746},{"date":"2025-08-01","current":-24.036552,"twenty":-46.041731,"median":-21.654595,"eighty":-6.726815,"marketCap":36002206719},{"date":"2025-08-08","current":-24.826165,"twenty":-46.009888,"median":-21.778972,"eighty":-6.77393,"marketCap":37277912217},{"date":"2025-08-15","current":-30.187957,"twenty":-45.956854,"median":-21.880814,"eighty":-6.801748,"marketCap":45261031102},{"date":"2025-08-22","current":-31.340447,"twenty":-45.877612,"median":-22.040069,"eighty":-6.818169,"marketCap":46841617672},{"date":"2025-08-29","current":-44.211377,"twenty":-45.754163,"median":-22.12704,"eighty":-6.826435,"marketCap":54981157612},{"date":"2025-09-05","current":-43.713127,"twenty":-45.754163,"median":-22.232203,"eighty":-6.87039,"marketCap":54307663321},{"date":"2025-09-12","current":-51.118552,"twenty":-46.009888,"median":-22.25754,"eighty":-6.902403,"marketCap":63622228082},{"date":"2025-09-19","current":-48.762854,"twenty":-46.166074,"median":-22.385207,"eighty":-6.913567,"marketCap":60647253248},{"date":"2025-09-26","current":-49.285185,"twenty":-46.470432,"median":-22.421162,"eighty":-6.952051,"marketCap":61137846832},{"date":"2025-10-03","current":-56.658472,"twenty":-46.589693,"median":-22.515713,"eighty":-6.977353,"marketCap":70452086727},{"date":"2025-10-10","current":-43.924146,"twenty":-46.730925,"median":-22.536332,"eighty":-6.992666,"marketCap":54537976918},{"date":"2025-10-17","current":-45.322401,"twenty":-46.679474,"median":-22.557787,"eighty":-7.033676,"marketCap":56230298432},{"date":"2025-10-24","current":-41.82388,"twenty":-46.590664,"median":-22.579804,"eighty":-7.044662,"marketCap":51908646920},{"date":"2025-10-31","current":-54.568601,"twenty":-46.591636,"median":-22.622109,"eighty":-7.066928,"marketCap":56507568311},{"date":"2025-11-07","current":-48.683596,"twenty":-46.7473,"median":-22.635169,"eighty":-7.067679,"marketCap":50381962610},{"date":"2025-11-14","current":-50.26971,"twenty":-46.7473,"median":-22.635169,"eighty":-7.067679,"marketCap":52170825166},{"date":"2025-11-21","current":-48.056736,"twenty":-46.7473,"median":-22.635169,"eighty":-7.067679,"marketCap":49850925917},{"date":"2025-11-28","current":-55.353486,"twenty":-46.7473,"median":-22.635169,"eighty":-7.067679,"marketCap":57628667207},{"date":"2025-12-05","current":-53.175722,"twenty":-46.7473,"median":-22.635169,"eighty":-7.067679,"marketCap":55456572634},{"date":"2025-12-12","current":-47.70417,"twenty":-46.71618,"median":-22.635169,"eighty":-7.067679,"marketCap":49842352617},{"date":"2025-12-19","current":-45.898361,"twenty":-46.491152,"median":-22.635169,"eighty":-7.067679,"marketCap":48068624555},{"date":"2025-12-24","current":-44.852205,"twenty":-46.431763,"median":-22.635169,"eighty":-7.067679,"marketCap":47119315185},{"date":"2026-01-02","current":-43.209809,"twenty":-46.059766,"median":-22.62473,"eighty":-7.067429,"marketCap":45572557526},{"date":"2026-01-09","current":-54.361718,"twenty":-46.046411,"median":-22.62473,"eighty":-7.067429,"marketCap":57477022292},{"date":"2026-01-16","current":-58.705072,"twenty":-46.046411,"median":-22.62473,"eighty":-7.067429,"marketCap":62270983104},{"date":"2026-01-23","current":-55.474266,"twenty":-46.046411,"median":-22.62473,"eighty":-7.067429,"marketCap":58787475911},{"date":"2026-01-30","current":-54.263588,"twenty":-46.046411,"median":-22.62473,"eighty":-7.067429,"marketCap":57767372054},{"date":"2026-02-06","current":-52.218951,"twenty":-46.046411,"median":-22.62473,"eighty":-7.067429,"marketCap":55731714052},{"date":"2026-02-13","current":-52.966724,"twenty":-46.058434,"median":-22.635169,"eighty":-7.067679,"marketCap":56854489965},{"date":"2026-02-20","current":-53.338987,"twenty":-46.024877,"median":-22.623419,"eighty":-7.067178,"marketCap":57171609271},{"date":"2026-02-27","current":-51.875191,"twenty":-46.024877,"median":-22.623419,"eighty":-7.067178,"marketCap":56212429905},{"date":"2026-03-06","current":74.472455,"twenty":-45.812516,"median":-22.557787,"eighty":-6.930348,"marketCap":59850278358},{"date":"2026-03-13","current":78.097154,"twenty":-45.574154,"median":-22.510897,"eighty":-6.811465,"marketCap":63052363742},{"date":"2026-03-20","current":81.998255,"twenty":-45.305708,"median":-22.371033,"eighty":-6.682285,"marketCap":65951271229},{"date":"2026-03-27","current":85.654278,"twenty":-44.919423,"median":-22.185244,"eighty":-6.578457,"marketCap":68716541229},{"date":"2026-04-02","current":103.802128,"twenty":-44.840252,"median":-22.040069,"eighty":54.425588,"marketCap":83808981763},{"date":"2026-04-10","current":94.551076,"twenty":-44.789217,"median":-21.859331,"eighty":62.169132,"marketCap":76928545449},{"date":"2026-04-15","current":104.320254,"twenty":-44.728018,"median":-21.714085,"eighty":64.250264,"marketCap":85061641097}],"updateTime":1776373899833},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09995\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604874184","title":"政策催化叠加价值兑现 国产创新药领域开启景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604874184","media":"制药网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604874184?lang=zh_cn&edition=fundamental","pubTime":"2026-01-19 13:44","pubTimestamp":1768801475,"startTime":"0","endTime":"0","summary":"多款国产新药密集获批、BD交易规模放量、海外临床进展提速,多重积极信号凸显行业高景气度,国产创新药正从研发驱动迈向价值兑现的关键阶段。根据数据统计,2026年开年以来,已有多款国产新药相继获批上市。进入2026年,国内创新药BD授权规模仍持续放量、合作模式升级。近年来,政策支持为行业发展保驾护航,叠加研发实力积累与商业化能力提升,国产创新药正迎来黄金发展时期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119134953a43b8e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06887","09995","01276","06978","02105","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604189821","title":"生物制品行业深度报告:MNC不断加码IO双抗,2026年重磅催化有望持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2604189821","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604189821?lang=zh_cn&edition=fundamental","pubTime":"2026-01-19 12:07","pubTimestamp":1768795650,"startTime":"0","endTime":"0","summary":"MNC不断加码IO双抗,2026年重磅催化有望持续目前全球共18款PD-1/VEGF双抗进入临床阶段,其中5款国产已BD出海。依沃西单抗:国内注册临床HARMONi-2和HARMONi-6试验OS数据有望于2026年成熟。海外临床目前围绕NSCLC进行全面布局,2025H2新开一项针对一线结直肠癌患者的美国注册临床。RC148:荣昌生物于近期与艾伯维达成6.5亿美元首付款及最高达49.5亿美元里程碑付款的独家授权许可协议。辉瑞已于2025年底开展SSGJ-707联合ITGB6ADC的I/II期临床,2026年有望开展更多联合ADC的探索性临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","HK0000252152.HKD","BK1161","HK0000252160.HKD","HK0000500386.USD","01877","LU2543165471.USD","09606","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604585011","title":"JPM大会落幕,开了个寂寞吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604585011","media":"医药财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604585011?lang=zh_cn&edition=fundamental","pubTime":"2026-01-19 09:17","pubTimestamp":1768785425,"startTime":"0","endTime":"0","summary":"2026年摩根大通医疗健康大会在旧金山落下帷幕。01 资本的理性:流动性困境与选择性复苏JPM大会的讨论揭示了一个清晰的现实:全球生物医药资本市场正在经历一场深刻的“选择性复苏”。在JPM的讨论中,几条现实路径被冷静地摆上台面。这种“靶向构建”策略在本次JPM大会上表现突出。03 交易盘点:流动性如何在实际中兑现本届JPM大会期间,一系列战略性交易勾勒出流动性兑现的多元图景。例如,Illumina在JPM上就特别提及中国市场的业务正在稳步恢复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011909215097a24c07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011909215097a24c07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","BK1583","09995","LU2328871848.SGD","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604637925","title":"IO+ADC战局悬念再起","url":"https://stock-news.laohu8.com/highlight/detail?id=2604637925","media":"药闻社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604637925?lang=zh_cn&edition=fundamental","pubTime":"2026-01-17 21:32","pubTimestamp":1768656777,"startTime":"0","endTime":"0","summary":"正是在这一背景下,IO + ADC不再只是单个项目的探索,而逐渐演变为一场关于治疗体系主导权的竞争。IO+ADC双重变量,让这个赛道的悬念又增加了几分。2025年2月,在PD-1赛道迟到的辉瑞,与Summit率先达成临床合作,共同探索PD-1/VEGF双抗AK112与ADC的联合治疗。从整体节奏来看,AK112 在 IO + ADC 体系化合作上的推进,明显慢于部分竞争对手。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117214350a7266c7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117214350a7266c7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1593","BK1161","09995","09926","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604942698","title":"外企高管转型中国创新药“推销员”,黄仁勋也来共享顶级资本盛宴","url":"https://stock-news.laohu8.com/highlight/detail?id=2604942698","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604942698?lang=zh_cn&edition=fundamental","pubTime":"2026-01-17 20:09","pubTimestamp":1768651740,"startTime":"0","endTime":"0","summary":"从一家跨国制药巨头高管到领导一家中国小型制药公司的角色转变,对Smiley来说,是容易也是不容易。他进一步称,中国的生物医药创新已经被全球认可,很多制药巨头也已经将中国创新能力视为管线的重要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117201636a7263ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117201636a7263ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","02142","03696","BK1574","06978","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604994460","title":"JPM大会上,5家最可能改变新年竞争格局的中国创新药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2604994460","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604994460?lang=zh_cn&edition=fundamental","pubTime":"2026-01-17 08:05","pubTimestamp":1768608319,"startTime":"0","endTime":"0","summary":"JPM 2026,共有24家中国创新药企在主会场和亚太专场亮相,还有更多的中国创新药企,在JPM 2026期间完成与MNC的重磅BD交易。在ADC、代谢疾病、细胞与基因治疗等JPM 2026上的热门领域,中国创新药已经成为不可或缺的价值输出方。在本文中,我们尝试基于JPM 2026期间的动向,找出可能改变2026年竞争格局的中国创新药企。这是JPM 2026议程正式启动后敲定的首笔BD交易,也是4天会期中首付款最高的BD交易,刷新了国内创新药单一管线BD首付款的记录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117080821a7249385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117080821a7249385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0561508036.HKD","LU1794554557.SGD","09995","IE00BPRC5H50.USD","LU2488822045.USD","BK1574","IE00B5MMRT66.SGD","LU0417516738.SGD","LU0348825331.USD","LU0634319403.HKD","LU0348735423.USD","LU0348827113.USD","BK1161","06978","LU0540923850.HKD","LU2476274308.USD","LU0417516571.SGD","LU1720050803.USD","LU0348766576.USD","LU0348767384.USD","LU2778985437.USD","LU1961090484.USD","LU2399975544.HKD","LU2476274720.SGD","LU0348784397.USD","09926","IE00B543WZ88.USD","LU0417516902.SGD","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603967864","title":"荣昌生物:公司尚无药品在欧盟获批上市,无药品向欧盟出口销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603967864","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603967864?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 18:25","pubTimestamp":1768559151,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问近两年是否出口欧盟国家?荣昌生物(688331.SH)1月16日在投资者互动平台表示,公司尚无药品在欧盟获批上市,无药品向欧盟出口销售,未来业务的开展情况,还请您关注公司的相关公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601163622035255.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163622035255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","688331","LU1064130708.USD","LU2488822045.USD","BK1574","BK0239","09995","LU2328871848.SGD","LU2148510915.USD","BK1161","BK1583","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603954004","title":"荣昌生物(09995)升3.45% 与艾伯维就RC148达成独家授权许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954004","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603954004?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 13:35","pubTimestamp":1768541754,"startTime":"0","endTime":"0","summary":"金吾财讯 | 荣昌生物(09995)股价午后维持高位,截至发稿,升3.45%,报97.65港元,成交额3.21亿港元。交银国际研究报告指,荣昌生物与艾伯维就RC148达成独家授权许可协议,后者将获得RC148大中华区以外开发、生产和商业化的独家权利,荣昌生物将收到6.5亿美元首付,并最高49.5亿美元的里程碑收款,以及两位数百分比的分级销售提成。该行上调荣昌生物2026至27年的收入预测,升目标价至136港元。2026年看好泰它西普和维迪西妥在海外注册研究上的进展,以及早期品种在更多适应症上的进展。","market":"other","thumbnail":"https://static.szfiu.com/news/20241105/OGZjY2Y5NjEzNTIxNjU5NDU5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241105/OGZjY2Y5NjEzNTIxNjU5NDU5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973389","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","688331","BK1161","LU2328871848.SGD","LU1064130708.USD","LU2148510915.USD","LU2488822045.USD","LU1064131003.USD","09995","BK1583","BK1574","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148959269","title":"异动解读 | 荣昌生物盘中大涨5.09%,因上调股份回购价格上限至116元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=1148959269","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148959269?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 09:44","pubTimestamp":1768527886,"startTime":"0","endTime":"0","summary":"荣昌生物(09995)今日盘中大涨5.09%,引发市场关注。消息面上,荣昌生物于1月15日召开董事会,审议通过《关于调整回购股份价格上限的议案》,拟将回购价格上限由人民币95元/股(含)调整为116元/股(含)。此次调整基于公司股票价格持续超出原回购价格上限,旨在保障回购方案顺利实施。除价格上限调整外,回购方案其他内容不变。分析人士指出,上调回购价格上限反映了公司管理层对当前股价的认可及对未来发展的信心,此举进一步提振了投资者情绪,推动股价上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603349619","title":"智通港股早知道 | 央行下调各类结构性货币工具25个基点 国家电网“十五五”计划投资4万亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603349619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603349619?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 07:52","pubTimestamp":1768521142,"startTime":"0","endTime":"0","summary":"修订后的eCTD相关技术文件由国家药监局药品审评中心另行发布。国家电网“十五五”计划投资4万亿元据中国电力报消息,国家电网“十五五”投资计划出炉:“十五五”期间,国家电网公司固定资产投资预计达到4万亿元,较“十四五”投资增长40%;将重点聚焦于绿色转型、构建新型电力系统、强化科技赋能等方面。持有屈臣氏集团25%股份的淡马锡寻求在其IPO中退出投资。双方所持股份均设有5年锁定期。2025年公司获得钠电千吨级订单并出货。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66a50ec980ff2cb7251ac80144af961f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1601","EVS.SI","BK4509","02579","BK4526","LU0052750758.USD","BK4532","ZFmain","ZBmain","BK1569","BK1592","BK4585","02465","BK1161","BK1594","603993","BK4574","UBmain","BK1230","BK4534","BK1116","LU1880383366.USD","LU1880383440.USD","TNmain","NIO","LU0164880469.USD","06936","ZNmain","BK1151","BK4099","LU0149721374.USD","LU0320764599.SGD","LU2213484517.USD","09995","300919","CKHUY","BK1190","002352","BK4548","NIO.SI","BK1574","03993","ZTmain","603906","LU1048588211.SGD","BK4581","BK1110","BK4588","BK1583","LU0708995583.HKD","BK4555","BK1500","00001","BK4505","LU1481107354.HKD","09866","BK1100","BK1521","BK4531","LU0072462343.USD","LU2328871848.SGD","02190","688331","IE0032431581.USD","LU1969619763.USD","BK1587","BK4504","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2603670626","title":"荣昌生物:调整回购股份价格上限至116元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603670626","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603670626?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 16:55","pubTimestamp":1768467316,"startTime":"0","endTime":"0","summary":"【荣昌生物:调整回购股份价格上限至116元/股】1月15日,荣昌生物公告称,公司拟将回购价格上限由95元/股调整为116元/股,以保障回购股份方案顺利实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620451798.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620451798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688331","LU1969619763.USD","BK0239","BK1574","LU2148510915.USD","LU2488822045.USD","LU2328871848.SGD","09995","LU1064131003.USD","LU1064130708.USD","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603841605","title":"研报掘金丨东北证券:维持荣昌生物“买入”评级,看好公司长期发展前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2603841605","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603841605?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 15:33","pubTimestamp":1768462431,"startTime":"0","endTime":"0","summary":"东北证券研报指出,荣昌生物RC148数据优异,BD交易超预期,看好公司长期发展前景。RC148系公司第四项成功的BD交易,公司研发能力与外资认可度实现充分验证。公司本次BD交易金额超预期,高额首付款直接改善荣昌生物的现金流,也体现了艾伯维对RC148底层数据的认可,为荣昌后续的研发和管线推进提供了极强的财务和品牌背书。随着公司上市核心产品加速放量、在研管线陆续获批及BD交易持续推进,看好公司远期发展前景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115153400a71d7b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115153400a71d7b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603262254","title":"《大行》交银国际升荣昌生物(09995.HK)目标价至136元 上调今明两年收入预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2603262254","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603262254?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 10:54","pubTimestamp":1768445640,"startTime":"0","endTime":"0","summary":"交银国际发表研究报告指,荣昌生物与艾伯维就RC148达成独家授权许可协议,后者将获得RC148大中华区以外开发、生产和商业化的独家权利,荣昌生物将收到6.5亿美元首付,并最高49.5亿美元的里程碑收款,以及两位数百分比的分级销售提成。该行认为,这项交易对康方、三生等已BD出海的同靶点产品的短期直接影响较为有限,考虑到它们在临床进展上已取得先发优势。该行上调荣昌生物2026至27年的收入预测,升目标价至136元。沽空资料截至 2026-01-14 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210305144101571_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496298/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1496298/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09995","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603027626","title":"华西证券:维持荣昌生物(09995)“增持”评级 RC148双抗56亿美元出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2603027626","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603027626?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 09:11","pubTimestamp":1768439514,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,华西证券发布研报称,维持荣昌生物“增持”评级,公司自主研发实力强劲,核心产品销售稳定增长,管理团队经验丰富,临床适应症管线稳定推进,海内外布局合理,看好公产品上市后商业化运营能力。根据协议,艾伯维将获得RC148在大中华区以外地区的独家开发、生产和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688331","09995","002926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603262688","title":"【券商聚焦】华泰证券:超预期创新药BD带动板块共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2603262688","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603262688?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 08:57","pubTimestamp":1768438620,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示,步入2026年以来,港股创新药交易不足两周,但已如该机构预期迎来开门红。港股创新药板块流动性大幅修复,且随着JPM医药峰会本周拉开序幕,中国BD交易持续超预期,相比去年同期有较大增长。该机构认为开年以来的流动性修复将带来一波明确的创新药β行情,该机构看好突破前高。外需型CXO在新分子需求的驱动下,业绩持续超预期,有望和创新药实现共振。该机构建议策略上优选中美估值差距较大的创新药资产相应公司;受益于新分子药物(多肽、寡核苷酸及ADC)的涌现,外需型CXO龙头凭借充沛的在手订单+强劲的漏斗效应,整体业绩已进入加速上升通道。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973256","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348783233.USD","LU0516422952.EUR","LU2097828714.EUR","LU1979443071.USD","01877","09926","BK1574","IE00BPRC5H50.USD","LU0140636845.USD","LU1719994722.HKD","LU0819121731.USD","02269","LU1934453819.USD","09995","LU0348827113.USD","01177","02142","BK1515","LU0856984785.SGD","LU1226288170.HKD","LU2328871848.SGD","LU1064131003.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","02616","LU0072913022.USD","BK1161","LU1303224171.USD","SG9999004220.SGD","06160","LU0823426480.USD","LU0348825331.USD","LU2476274308.USD","06185","BK1588","601688","06978","LU1688375341.USD","LU1993786604.SGD","LU1961090484.USD","BK1610","01093","159992","LU0561508036.HKD","SG9999002463.SGD","09688","LU1251922891.USD","01801","LU2488822045.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603603070","title":"艾伯维与荣昌生物达成重磅合作!56亿美元共同开发实体瘤双特异性抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603070","media":"药事纵横","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603603070?lang=zh_cn&edition=fundamental","pubTime":"2026-01-15 06:03","pubTimestamp":1768428226,"startTime":"0","endTime":"0","summary":"1月12日,艾伯维与荣昌生物联合宣布,双方已就RC148的全球开发、生产与商业化达成独家许可协议。RC148是一款由荣昌生物自主研发、处于临床阶段的新型PD-1/VEGF双特异性抗体,目前正在多项晚期实体瘤中开展单药及联合方案研究。早期临床研究中,RC148联合ADC已初步显示出良好的抗肿瘤活性。荣昌生物将获得6.5亿美元首付款,并有资格在未来收取最高49.5亿美元的开发、注册及销售里程碑付款,以及大中华区外净销售额的分级两位数特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011506045297a1d676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011506045297a1d676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","LU2328871848.SGD","LU1969619763.USD","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603130816","title":"向“领跑者”跨越! 中国双抗药物再迎高光时刻","url":"https://stock-news.laohu8.com/highlight/detail?id=2603130816","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603130816?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 20:14","pubTimestamp":1768392877,"startTime":"0","endTime":"0","summary":"2026年1月12日,第四十四届摩根大通医疗健康大会在美国旧金山召开,当全球生物医药界的目光聚焦于该会议时,大洋彼岸的中国接连传来重磅消息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601143619177920.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601143619177920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1829250122.USD","LU0634319403.HKD","09995","LU0348784397.USD","GSK","BK4195","LU1961090484.USD","LU0348766576.USD","LU0348783233.USD","BK4107","LU0053666078.USD","GSK.UK","BK1161","LU0348735423.USD","LU1969619763.USD","LU0417516738.SGD","LU0348767384.USD","BK4532","LU2399975544.HKD","LU0417516571.SGD","BK1574","LU0348825331.USD","LU0348827113.USD","IE00B5MMRT66.SGD","LU2328871848.SGD","LU2488822045.USD","IE00BPRC5H50.USD","LU2476274720.SGD","LU0540923850.HKD","IE00B543WZ88.USD","BK4588","LU0561508036.HKD","BK4585","BK1583","LU2778985437.USD","LU1794554557.SGD","LU0417516902.SGD","BK4007","BMS","09926","LU2476274308.USD","L","ORR","LU2487616109.SGD","PFS","BK4211","LU1720050803.USD","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603445596","title":"荣昌生物56亿美元订单背后:纾困之后,如何突围创新药深水区?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603445596","media":"YD中孚财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603445596?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 19:20","pubTimestamp":1768389602,"startTime":"0","endTime":"0","summary":"2026年1月12日,荣昌生物制药(烟台)股份有限公司(下称“荣昌生物,688331.SH)与艾伯维达成的56亿美元授权合作,为年初冷清的生物医药赛道投下一颗重磅炸弹。这笔创下中国Biotech海外授权首付款及总里程碑金额纪录之一的交易,不仅让荣昌生物获得折合人民币约45.33亿元的确定性首付款,更点燃了市场对其摆脱经营困境的期待。可分析公司最新财务数据、核心产品现状及PD-(L)1/VEGF双抗","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114205041a4c35bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114205041a4c35bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","LU2328871848.SGD","BK1161","LU1969619763.USD","06978","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603628329","title":"艾伯维再砸下56亿美元!为什么MNC热衷双抗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603628329","media":"动脉新医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603628329?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 18:58","pubTimestamp":1768388288,"startTime":"0","endTime":"0","summary":"1月12日晚,荣昌生物宣布与艾伯维签署独家授权协议,将自主研发的PD-1/VEGF双特异性抗体药物RC148的大中华区以外全球权益授权给后者。毋庸置疑,双抗赛道诞生重磅交易已不是一件新鲜事,辉瑞、BMS和艾伯维等MNC也被卷入。正是看到这一价值,艾伯维、辉瑞等MNC纷纷重金布局,以期争夺下一代基石药物的主导权。针对荣昌生物与艾伯维达成的重磅BD,前述医药行业分析师告诉动脉网,早期交易多以new-co形式进行,而本次是直接的BD授权,且交易对手是MNC。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190019a4c2fb59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114190019a4c2fb59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","LU0348783233.USD","LU0417516902.SGD","BK1574","IE00B543WZ88.USD","LU2476274308.USD","IE00BPRC5H50.USD","LU1969619763.USD","BK1583","01541","LU0348735423.USD","LU0634319403.HKD","LU1961090484.USD","LU0417516738.SGD","LU2476274720.SGD","IE00B5MMRT66.SGD","LU0417516571.SGD","LU1794554557.SGD","LU0561508036.HKD","LU0540923850.HKD","LU2399975544.HKD","LU0348825331.USD","LU0348766576.USD","LU1720050803.USD","09995","LU2488822045.USD","LU0348784397.USD","BK1161","LU0348767384.USD","LU2328871848.SGD","LU0348827113.USD","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603942046","title":"2026开年,创新药迎来暖风","url":"https://stock-news.laohu8.com/highlight/detail?id=2603942046","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603942046?lang=zh_cn&edition=fundamental","pubTime":"2026-01-14 17:39","pubTimestamp":1768383558,"startTime":"0","endTime":"0","summary":"2026年开年以来,创新药板块的情绪明显回暖。进入2026年,这一趋势并未放缓。开年不足半月,整体创新药行业的BD交易高达14起,覆盖小核酸、ADC、双抗、炎症免疫小分子及 AI 制药等多个技术方向。2026年被普遍视为其关键拐点之年,全球医药圈频频传来利好消息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114174511a719ab7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114174511a719ab7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09995","06938","06978"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}